Jazz Pharmaceuticals Sues Teva Over Alleged Patent Infringement on Narcolepsy Drug Xywav

Teva Pharmaceuticals Inc. is facing legal action from Jazz Pharmaceuticals Inc. over an alleged patent infringement concerning the narcolepsy medication Xywav. In a recently filed complaint, Jazz accuses Teva of unlawfully infringing on their patented technology for Xywav, bringing the suit to the New Jersey federal court. The specifics of the complaint detail how Teva’s actions potentially violate Jazz’s intellectual property rights pertaining to this essential narcolepsy treatment. For further details, you can access the complaint and learn more about the case here.